Patterson Dental Topical Anesthetic Recalled for Manufacturing Quality Defect
Keystone Industries is recalling one lot of Patterson Dental Topical Anesthetic due to manufacturing quality deviations. The product was shipped despite being marked for rejection due to scratches in the mixing vessel.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves a CGMP deviation (damaged mixing vessel) with no reported illnesses, injuries, or confirmed contamination. Per the severity rubric, precautionary recalls with only theoretical hazard and no reported harm are classified as Moderate.
Plain-English summary
Patterson Dental Topical Anesthetic (benzocaine), manufactured by Keystone Industries, is being recalled. The affected lot is BNZ-001646 (NDC 50227-1002-3) with an expiration date of November 26, 2026.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations identified during routine quality inspection. Scratches were discovered on the sides and bottom of the mixing vessel used to produce this batch. Although the Quality Unit marked the product for rejection due to these manufacturing defects, it was inadvertently shipped to customers.
The affected product was distributed nationwide in the United States and Canada, as well as to the Dominican Republic, El Salvador, Honduras, and Qatar.
The recalled product
- Product
- PATTERSON DENTAL TOPICAL ANESTHETIC (BENZOCAINE)
- Brand
- PATTERSON DENTAL TOPICAL ANESTHETIC
- Manufacturer
- Keystone Industries
- Category
- Drug — Topical Anesthetic
- Hazard
- manufacturing-defect
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: BNZ-001646
- Exp Date: 11/26/2026
- Keystone Item No. 03-27119
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27